Benzinga's Top Upgrades

Analysts at Mizuho Securities upgraded LifePoint Hospitals

from “neutral” to “buy.” The target price for LifePoint Hospitals has been raised from $58 to $72. LifePoint's shares closed at $60.87 yesterday. Raymond James upgraded Amsurg

from “market perform” to “strong buy.” The target price for Amsurg is set to $60. Amsurg's shares closed at $45.74 yesterday. Analysts at JP Morgan upgraded Avery Dennison

from “neutral” to “overweight.” The target price for Avery Dennison has been raised from $52 to $58. Avery Dennison's shares closed at $49.21 yesterday. Analysts at Northland Securities upgraded OmniVision Technologies

from “market perform” to “outperform.” The target price for OmniVision Technologies has been raised from $21 to $28. OmniVision's shares closed at $20.14 yesterday.